10 000 Babies/Year to be Screened for Diabetes Risk Genes in Sweden.Medical & Health Writers STOCKHOLM, Sweden--(BW HealthWire)--May 26, 2000 Publicly traded Diamyd Medical, Stockholm, Sweden, (Reuter: DIAMb.epfn; Bloomberg: Diam b SS) announces that efforts are now under way at the University of Lund, Sweden, to identify individuals at risk to develop insulin insulin, hormone secreted by the β cells of the islets of Langerhans, specific groups of cells in the pancreas. Insufficiency of insulin in the body results in diabetes. Insulin was one of the first products to be manufactured using genetic engineering. dependent diabetes. This group may then be in need of diabetes prevention intervention A procedure used in a lawsuit by which the court allows a third person who was not originally a party to the suit to become a party, by joining with either the plaintiff or the defendant. with the diabetes vaccine vaccine Preparation containing either killed or weakened live microorganisms or their toxins, introduced by mouth, by injection, or by nasal spray to stimulate production of antibodies against an infectious agent. Diamyd, should this vaccine prove successful in coming clinical Phase II and III studies. "About 10 000 newborns in the southern region of Sweden region will be screened per year for diabetes risk genes and risk antibodies" says Swedish Professor Ake Lernmark, University of Washington, USA, and member of Diamyd Medical's Scientific and Medical Advisory Board. "We estimate that 25% percent of these may be singled out as risk individuals and these will be closely monitored over the years to follow for development of diabetes related antibodies such as GAD Gad, in the Bible, son of Jacob and Zilpah and eponymous founder of one of the 12 tribes of Israel. Its allotment was half of Gilead; this was the land best suited to the pastoral life, which Gad, like Reuben, continued after the years in Egypt. ." From the ethical point of view it has been questioned if at-risk individuals are to be identified while there is no diabetes prevention currently available. After careful consideration the identification program has been allowed however but mothers will not be informed if their babies are at risk until a safe and efficient diabetes prevention vaccine is available. "We are excited to see this field move forwards", says Anders Essen-Moller, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Diamyd Medical. "If our planned Phase II diabetes prevention studies in LADA LADA Larga Distancia (Spanish: Long distance telephone services) LADA Langkawi Development Authority (Malaysia) LADA Laser-Assisted Device Alteration LADA Light Air Defense Artillery patients are successful - which we should know in about 12 months - diabetes prevention in the young is certainly the next and ultimate goal and a prerequisite pre·req·ui·site adj. Required or necessary as a prior condition: Competence is prerequisite to promotion. n. for success is careful selection of individuals at high risk to develop diabetes." The foregoing information includes statements concerning both present status and forward-looking items. This information is to the "best of knowledge" of the management of Diamyd Medical only and the actual status and results achieved by the Company may differ materially from these statements. The Company assumes no obligation to update these statements to reflect actual results, changes in assumptions or changes in other factors affecting such statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion